Regeneron Pharmaceuticals, Inc. (REGN) — Stock Analysis & Fair Value

Regeneron Pharmaceuticals, Inc. (REGN) trades on NASDAQ at $816.10 (US). Market cap $84.02B. P/E 19.2. P/B 2.6. ROE 13.8%. dividend yield 0.5%. 52-week range $575.93–$859.34.

Sector: Healthcare — Biotechnology.

On getValue you can run 9 valuation models on REGN — DCF, Reverse DCF, Dividend Discount Model (DDM), Cash Flow + IRR, Normalized P/E, Industry Multiple, Piotroski F-Score and NAV — alongside a WACC calculator, up to 10 years of income statement, balance sheet and cash-flow data, peer comparison and insights.

Open the full REGN analysis · Key metrics & insights

getValue is an analysis tool for education, not investment advice. Figures are shown as reported; model outputs depend on your assumptions.